Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and Implications

作者: Fabrice Andre , Dominique Grunenwald , Jean-Pierre Pignon , Antoine Dujon , Jean Louis Pujol

DOI: 10.1200/JCO.2000.18.16.2981

关键词:

摘要: PURPOSE: Patients who suffer from non–small-cell lung cancer (NSCLC) with ipsilateral mediastinal lymph node involvement (N2) belong to a heterogeneous subgroup of patients. We analyzed the prognosis patients resected N2 NSCLC propose homogeneous patient subgroups. PATIENTS AND METHODS: The present study comprised 702 consecutive six French centers underwent surgical resection NSCLC. Initially, two groups were defined: clinical (cN2) and those minimal (mN2) disease in whom was not detected preoperatively at computed tomographic scan, respectively. RESULTS: median duration follow-up 52 months (range, 18 120 months). A multivariate analysis using Cox regression identified four negative prognostic factors, namely, cN2 status (P < .0001), multiple levels (L2+; P pT3 T4 stage no preoperative chemotherapy .01). For treated wi...

参考文章(37)
F.G. Pearson, N.C. DeLarue, R. lives, T.R.J. Todd, J.D. Cooper, Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 83, pp. 1- 11 ,(1982) , 10.1016/S0022-5223(19)37318-0
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
K S Albain, V W Rusch, J J Crowley, T W Rice, A T Turrisi, J K Weick, V A Lonchyna, C A Presant, R J McKenna, D R Gandara, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Journal of Clinical Oncology. ,vol. 13, pp. 1880- 1892 ,(1995) , 10.1200/JCO.1995.13.8.1880
N C Choi, R W Carey, W Daly, D Mathisen, J Wain, C Wright, T Lynch, M Grossbard, H Grillo, Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer Journal of Clinical Oncology. ,vol. 15, pp. 712- 722 ,(1997) , 10.1200/JCO.1997.15.2.712
W Eberhardt, H Wilke, G Stamatis, M Stuschke, A Harstrick, H Menker, B Krause, M R Müeller, M Stahl, M Flasshove, V Budach, D Greschuchna, N Konietzko, H Sack, S Seeber, Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. Journal of Clinical Oncology. ,vol. 16, pp. 622- 634 ,(1998) , 10.1200/JCO.1998.16.2.622
Peter Goldstraw, Gopi C. Mannam, David K. Kaplan, Panos Michail, Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease) The Journal of Thoracic and Cardiovascular Surgery. ,vol. 107, pp. 19- 28 ,(1994) , 10.1016/S0022-5223(94)70447-3
Tsuguo Naruke, Keiichi Suemasu, Shichiro Ishikawa, Lymph node mapping and curability at various levels of metastasis in resected lung cancer. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 76, pp. 832- 839 ,(1978) , 10.1016/S0022-5223(19)39559-5
J F Vansteenkiste, S G Stroobants, P R De Leyn, P J Dupont, J Bogaert, A Maes, G J Deneffe, K L Nackaerts, J A Verschakelen, T E Lerut, L A Mortelmans, M G Demedts, Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. Journal of Clinical Oncology. ,vol. 16, pp. 2142- 2149 ,(1998) , 10.1200/JCO.1998.16.6.2142
S Burdett, MKB Parmar, LA Stewart, RL Souhami, R Arriagada, DJ Girling, JP Pignon, V Torri, AH Brichet, JJ Lafitte, B Dautzenberg, M Debevec, V Kovac, RJ Stephens, A Gregor, S Piantadosi, P Rocmans, Paul Van Houtte, M Wang, Postoperative radiotherapy in nonsmall-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials The Lancet. ,vol. 352, pp. 257- 263 ,(1998) , 10.1016/S0140-6736(98)06341-7